News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Paolo Tarantino: Make sure not to miss our presentation of RELIEVE at the San Antonio Breast Cancer Symposium (SABCS23)
Photo of Paolo Tarantino from X
Nov 6, 2023, 04:03

Paolo Tarantino: Make sure not to miss our presentation of RELIEVE at the San Antonio Breast Cancer Symposium (SABCS23)

Paolo Tarantino, Research Fellow at the Dana-Farber Cancer Institute, shared on X/Twitter:

“Trastuzumab Deruxtecan (T-DXd) outperformed chemo for the treatment of HER2-low Metastatic Breast Cancer (MBC). But how does it perform among patients with dynamic changes in HER2 status? Does it also work if the most recent biopsy was HER2-0? Make sure not to miss our presentation of RELIEVE at the San Antonio Breast Cancer Symposium (SABCS23)!”

Image

Source: Paolo Tarantino/Twitter

cancer Dana-Farber Cancer Institute metastatic breast cancer OncoDaily Oncology Paolo Tarantino RELIEVE SABCS23 San Antonio Breast Cancer Symposium
Special Coverage
Blog
Dec 22, 2024, 05:13
The Connell and O’Reilly Families Cell Manipulation Core Facility at Dana-Farber Cancer Institute
Blog
Dec 22, 2024, 05:05
Ruben Mesa: Excited to visit Atrium Health Levine Cancer Pineville
Blog
Dec 22, 2024, 05:02
Muhammad Umair Mushtaq: Are Stem Cell Transplants Safe for Myelofibrosis Patients Over 70?
Blog
Dec 22, 2024, 05:00
Elvina Almuradova: Being a part of Giuseppe Curigliano's team is an invaluable scientific milestone for me
Blog
Dec 22, 2024, 04:58
Summary slide for PFS in selected trials by IGHV status caveat for CLL by Nitin Jain
Insight
Dec 22, 2024, 04:53
Cancer survivors are growing in number - National Cancer Institute
Blog
Dec 22, 2024, 04:52
Registration is open for the ESMO Gastrointestinal Cancers Congress 2025
Blog
Dec 22, 2024, 04:49
Amalya Sargsyan: New ESO Rare Cancer Series podcast with Salvatore Provenzano
Insight
Dec 22, 2024, 04:47
Journal of Psychosocial Oncology Research and Practice: Vol. 6, Number 4 - IPOS
Science
Dec 22, 2024, 04:40
The prevalence of widespread guideline-discordant LDCT screening in a low-risk population by So Yeon Kim et al.
Blog
Dec 22, 2024, 04:38
The new Institute of Cancer Research spinout company Sentinal4D has been announced to the public
Blog
Dec 22, 2024, 04:34
Nermean Mostafa: Honored to co-organize women cancer patient advocacy session hosted by 8th Gyne-Oncology conference